What It Is

Fibromyalgia is a chronic widespread pain condition characterized by musculoskeletal pain throughout the body, persistent fatigue, unrefreshing sleep, cognitive difficulties often called fibro fog, and heightened sensitivity to painful stimuli. It affects an estimated 2 to 4 percent of Americans, and women are diagnosed significantly more often than men — though whether that reflects true prevalence or diagnostic bias is an open question worth asking.

The official explanation for fibromyalgia is central sensitization — the nervous system's pain volume has been turned up. The amplifier is broken, not the signal. Pain that would register as minor in a normally calibrated nervous system registers as severe and widespread. The pain is real. The mechanism, as currently understood, is neurological rather than inflammatory or structural.

There is no blood test for fibromyalgia. There is no imaging finding. Diagnosis is clinical — built from symptom history, duration, distribution of pain, and the exclusion of other conditions. That last part — the exclusion of other conditions — is where the diagnostic process most frequently fails the patient.

The Misdiagnosis Problem

Fibromyalgia is simultaneously underdiagnosed and overdiagnosed, often in the same clinical settings. A study published in Arthritis Care and Research examined 497 patients at a university rheumatology clinic and found that physicians failed to identify nearly half of patients who actually met fibromyalgia criteria — while incorrectly diagnosing the condition in over 11 percent of patients who did not meet criteria. Overall agreement between clinician diagnosis and published criteria was described as only fair, with researchers concluding that diagnostic problems including clinician bias and the meaning of the fibromyalgia diagnosis itself were substantial. ScienceDaily

What this means in plain language: fibromyalgia is frequently handed to patients who have something else, and frequently missed in patients who genuinely have it. The label gets applied to widespread pain and fatigue when the workup hasn't gone far enough — and it sticks, because fibromyalgia is a diagnosis of exclusion with no objective confirming test. Once it's in the chart, the search for upstream causes often stops.

Evidence-based guidelines have noted that fibromyalgia as a standalone diagnosis is uncommon — most patients who meet criteria also meet criteria for other chronic overlapping pain conditions or mental disorders, and a complete medical history and physical examination is mandatory to identify features that may point to another condition with a similar presentation. PubMed

The conditions most commonly confused with fibromyalgia or missed underneath it include hypothyroidism, rheumatoid arthritis, lupus, Sjogren's syndrome, ME/CFS, small fiber neuropathy, Lyme disease, and inflammatory myopathies. What is almost never on that differential list — and what this page argues belongs there — is hypertriglyceridemia-induced peripheral neuropathy.

The Triglyceride Question Nobody Is Asking

This is the section that does not exist anywhere else in the fibromyalgia literature in plain language. It needs to.

High triglycerides are not just a cardiovascular risk number. They are a direct cause of peripheral nerve damage and widespread pain — documented in peer-reviewed medical literature, known to neurologists, and almost entirely absent from the conversation happening in fibromyalgia clinics, ME/CFS support groups, and chronic pain communities.

The mechanism is not complicated. High triglyceride levels induce microangiopathy — damage to small blood vessels — leading to reduced blood supply to small nerve fibers, in a process similar to the mechanism seen in diabetic neuropathy. PubMed Central The small vessels that feed the peripheral nerves get compromised. The nerves stop receiving adequate blood flow and oxygen. They begin to malfunction and produce pain signals. The pain is real. The source is circulatory and metabolic — not central sensitization.

A study examining 24 patients with triglyceride levels above 300 mg/dL and no neurological complaints found that 70.8 percent showed significant nerve conduction delays in the sural nerves and 66.7 percent showed delays in median sensory fibers — consistent with early peripheral neuropathy, despite having no symptoms yet. PubMed The nerve damage was happening silently before the pain began.

A PubMed case report documented severe peripheral neuropathy caused by hypertriglyceridemia in a patient where all other standard causes of neuropathy — thyroid, glucose, B12, kidney function, autoimmune markers — were normal. Hypertriglyceridemia was identified as the likely etiology. The authors noted that peripheral nerve conduction abnormalities can be identified in patients with even mild hypertriglyceridemia in the absence of symptoms, and that early recognition and aggressive management may prevent progression to severe neuropathy. PubMed

A University of Michigan study analyzing data from 427 diabetes patients with neuropathy found that elevated triglycerides were the most accurate predictor of worsening nerve fiber loss over one year — more predictive than elevated blood glucose or other lipid markers. The researchers concluded that the same lipid particles contributing to cardiovascular disease are also key players in peripheral nerve fiber loss. ScienceDaily

Think of it this way. Sit on your hand for five minutes. When the circulation returns, you feel pins and needles — every nerve in that hand waking up simultaneously as blood flow restores. That is a normal nervous system experiencing temporary vascular compromise. Now imagine that process happening at a lower level, continuously, throughout every muscle and nerve in your body — because the blood running through your small vessels is thick with triglycerides and cannot adequately perfuse the capillary beds that feed your peripheral nerves. The pain is not imaginary. The amplifier is not broken. The pipes are clogged.

That is not fibromyalgia. That is a circulation and metabolic problem with a measurable number on a standard lipid panel and a specific indicated treatment — fenofibrate, not a fibromyalgia medication.

Critical note on treatment: Statins do not treat elevated triglycerides. Statins treat LDL cholesterol. Fenofibrate is the medication indicated for elevated triglycerides. These are not the same drug class treating the same problem. If your triglycerides are elevated and you have been prescribed a statin, ask your physician specifically about fenofibrate. Ask by name.

Symptoms

Fibromyalgia as officially defined presents with widespread musculoskeletal pain lasting three months or more, covering multiple body regions — both sides of the body, above and below the waist. Additional features include persistent fatigue that is not relieved by sleep, unrefreshing sleep, cognitive difficulties including memory and concentration problems, heightened sensitivity to touch, light, sound, and temperature, headaches, and mood disturbance including anxiety and depression.

The pain of fibromyalgia is characteristically diffuse rather than localized, without objective signs of inflammation — no swelling, no elevated inflammatory markers on standard labs, no structural findings on imaging. This absence of objective findings is part of what makes the diagnosis both recognizable and unreliable — it matches the presentation of many other conditions equally well.

What fibromyalgia shares with hypertriglyceridemia-induced neuropathy: widespread pain, fatigue, cognitive fog, sensitivity, sleep disruption. What potentially distinguishes them: hypertriglyceridemia-induced neuropathy has a measurable cause on a lipid panel, responds to fenofibrate treatment, and may produce nerve conduction abnormalities detectable on testing even before symptoms appear. Fibromyalgia has none of those anchors.

The question worth asking before accepting the fibromyalgia label is simple: has anyone checked the triglycerides, explained what high triglycerides actually do to small blood vessels and peripheral nerves, and discussed fenofibrate as a treatment option if the numbers are elevated?

Overlap With ME/CFS and Hashimoto's Thyroiditis

Fibromyalgia overlaps significantly with both ME/CFS and Hashimoto's thyroiditis in symptom presentation — widespread pain, fatigue, cognitive fog, sleep disruption, mood disturbance. The three conditions are frequently confused with each other and frequently co-occur. A patient carrying one of these diagnoses should be evaluated for the others, not reassured that one label explains the full picture.

ME/CFS is distinguished by post-exertional malaise — the characteristic worsening of all symptoms following physical or cognitive exertion, often delayed by 12 to 48 hours. This pattern is specific enough to be diagnostically meaningful. Fibromyalgia does not require post-exertional malaise by definition, though some patients experience it.

Hashimoto's thyroiditis produces widespread pain and fatigue through thyroid hormone insufficiency — a treatable hormonal problem that can look identical to fibromyalgia on symptom presentation and is frequently missed when only TSH is checked rather than free T4, free T3, and thyroid antibodies. A full thyroid panel is not optional in the workup of widespread chronic pain.

If elevated triglycerides, NAFLD, or reactive hypoglycemia are part of your picture alongside widespread pain and fatigue, hereditary fructose intolerance is worth considering as a possible upstream cause. See the HFI page in the Metabolic and Genetic section of the Medical Library.

What You Can Do About It

If you carry a fibromyalgia diagnosis and nothing has improved — ask for a full lipid panel with triglycerides specifically reported and discussed, not just flagged as a number in a lab report. Ask what your triglyceride level means for nerve health and small vessel circulation. Ask about fenofibrate specifically if triglycerides are elevated. Ask for a full thyroid panel — not just TSH. Ask about celiac disease if you have not been tested. Ask about HFI if reactive hypoglycemia is part of your history.

The fibromyalgia diagnosis should be earned by eliminating the conditions that look like it — not handed out because the pain is real and the standard workup came back normal. A normal standard workup and a real symptom picture means the right test has not been run yet, not that the answer is fibromyalgia.

Rheumatology wait times are long — often nine months to a year in many parts of the country. Start the conversation with your primary care physician now. Ask for the lipid panel. Ask for the full thyroid panel. Get the numbers in your hands and understand what they mean before you wait a year for a specialist who may hand you the same label with a different medication.

Personal Note

I want to say something plainly that I have not seen said on any fibromyalgia page anywhere: I think a significant number of people carrying this diagnosis have never had their triglyceride levels meaningfully checked, explained, or treated — and some of them are living in the pain that results from that gap.

I know what hypertriglyceridemia-induced neuropathy feels like from the inside because I lived in it for over two years. As my triglycerides climbed higher and higher, I got worse and worse. The mechanic's brain eventually worked it out: the blood was too thick to reach the small vessels. The capillaries were not getting adequate flow. Energy was being produced but could not be delivered to the muscles and nerves that needed it. Fixer cells could not get where they needed to go. I was one big purple finger with a string tied around it — every muscle, every nerve, slowly being starved of circulation while I tried to figure out why I was disappearing.

The pain during that period was nonstop. Everywhere. Every joint, every muscle, every moment. Most people have no reference point for that level of sustained pain because nothing in normal life produces it at that scale and duration. The closest I can describe it is this: imagine being forced to run three marathons in a row without sleep or food for three days. That gives you maybe a fraction of what it felt like to exist in that body. I would not wish it on my worst enemy.

Then I got fenofibrate. Four or five days for it to start working. And when it kicked in — when the triglycerides dropped to a level where the blood could start moving through the small vessels again — it was not relief. It was ten times the pain I had been experiencing for two years, for seven days straight. My entire body waking up simultaneously. Every muscle, every nerve, coming back online at once. The whole-body version of a limb that fell asleep — except it was everything, all at once, for a week, with no physician present, in the middle of COVID lockdowns, completely alone.

Nobody warned me that was coming. Nobody monitored it. The right medication was working exactly as it should — and the process of it working nearly broke me all over again.

I want anyone reading this who is currently in that level of pain to know two things. First: check the triglycerides. Get the actual number. Understand what it means. Ask about fenofibrate by name. Second: if fenofibrate is prescribed and it starts working, the return of circulation to long-compromised nerves is not comfortable. It is the opposite of comfortable. Push through it. That pain is the body coming back to life, not the treatment failing.

I have asked thousands of people in ME/CFS, long COVID, and celiac support communities whether their triglyceride levels had ever been checked, discussed, or explained to them in the context of their pain. Not one person confirmed that conversation had ever happened with their physician. Not one. In some of those groups, I was removed for asking the question — as if checking a standard lab value was somehow outside the boundaries of a chronic illness conversation.

I have a family member twenty years older than me with the same symptom picture I had — lifetime of reactive hypoglycemia, widespread pain, fatigue, cognitive fog — diagnosed with fibromyalgia and on fibromyalgia medication for years with zero improvement. Never tested for celiac. Never tested for HFI. Still eating grains and a high carbohydrate diet. I cannot make that choice for her. All I can do is put this information somewhere it can be found by the person who is finally ready to ask a different question.

I understand why some people in that level of chronic pain turn to whatever gets them through the day — marijuana, prescription stimulants, or worse. I thought about it. When your body cannot produce or deliver energy through normal pathways, anything that forces the adrenal system to fire feels like temporary relief. Prednisone does it. Methamphetamine does it. Neither one fixes the nail. The spare tire gets you to the next gas station — it does not solve the problem. I was fortunate enough to have planned ahead for hard times and could survive on very little while I kept searching for the real answer. Not everyone has that margin. I am not judging anyone who runs out of margin before they find the answer. I am trying to make the answer easier to find.

The nail in my tire was triglycerides. The right wrench was fenofibrate to get me to the next gas station where I found the right tools to diagnose the Celiac and HFI and get off the fenofibrate. Nobody handed me either one. I had to find them myself. I hope this can be the right wrench you all have needed for so long.

I'm not a doctor. I'm not telling you to change your medication. Everything here is personal testimony and links to real medical sources. Always work with a qualified physician. But ask for the triglycerides. Ask for fenofibrate by name if the number is high. Ask what nobody asked you before.

Sources

• Wolfe F, et al. "Diagnosis of fibromyalgia: disagreement between fibromyalgia criteria and clinician-based fibromyalgia diagnosis in a university clinic." Arthritis Care and Research, 2019. PubMed.

• Sarzi-Puttini P, et al. "Fibromyalgia syndrome: under-, over- and misdiagnosis." Clinical and Experimental Rheumatology, 2019. PubMed.

• Kaseem M, et al. "Hypertriglyceridemia and peripheral neuropathy in neurologically asymptomatic patients." PubMed, 2006.

• Batchelor P. "Polyradiculopathy secondary to severe hypertriglyceridemia." BMJ Case Reports, 2015. PMC.

• McManis PG, Windebank AJ, Kiziltan M. "Neuropathy associated with hyperlipidemia." Neurology, 1994. Mayo Clinic/Neurology journal.

• Pop-Busui R, et al. "Elevated triglycerides correlate with progression of diabetic neuropathy." Diabetes, 2009. PMC.

• University of Michigan. "Triglycerides implicated in diabetes nerve loss." ScienceDaily, 2009.